Inventor · disambiguated record
Courtney A. Cullis
Also filed as: CULLIS COURTNEY · CULLIS COURTNEY A
15 granted patents·9 pending applications·91 citations·filing 2003–2025
92Inventor score
Files withMILLENNIUM PHARM INC14DANA FARBER CANCER INST INC4TAKEDA PHARMACEUTICALS CO2ABBOTT LAB1BLACKBURN CHRISTOPHER1
Top patents by PatentIndex Score
24 records- 0197US8008307B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2007·Granted Aug 30, 2011·25 cites·17 claims
- 0295US8481550B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesCLAIBORNE CHRISTOPHER F·Filed 2011·Granted Jul 9, 2013·19 cites·14 claims
- 0393US8901136B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2013·Granted Dec 2, 2014·12 cites·9 claims
- 0491US7935694B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted May 3, 2011·8 cites·22 claims
- 0590US7459448B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2005·Granted Dec 2, 2008·8 cites·22 claims
- 0682US9751854B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2016·Granted Sep 5, 2017·3 cites·8 claims
- 0781US9802960B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Oct 31, 2017·4 cites·29 claims
- 0879US11542293B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 3, 2023·1 cites·23 claims
- 0975US2025340534A1Allosteric egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 1075US2025340535A1Allosteric egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 1173US10202373B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Feb 12, 2019·2 cites·15 claims
- 1272US12391671B2Allosteric EGFR inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2022·Granted Aug 19, 2025·0 cites·29 claims
- 1371US6921821B2Antagonists of melanin concentrating hormone receptorABBOTT LAB·Filed 2003·Granted Jul 26, 2005·7 cites·23 claims
- 1470US12054512B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 6, 2024·0 cites·23 claims
- 1562US8859768B2Heteroaryls and uses thereofCULLIS COURTNEY A·Filed 2011·Granted Oct 14, 2014·2 cites·28 claims
- 1659US2012178739A1Lactam compounds useful as protein kinase inhibitorsBLACKBURN CHRISTOPHER·Filed 2012·Application pending·0 cites
- 1753US2005245563A1Chk-1 inhibitorsMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 1852US10538533B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2017·Granted Jan 21, 2020·0 cites·23 claims
- 1952US2011039820A1Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 2051US2013165472A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 2151US2013165483A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 2251US2013165464A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 2349US12377080B2Allosteric EGFR inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Aug 5, 2025·0 cites·20 claims
- 2443US2006035920A1Chk-1 inhibitorsMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Courtney A. Cullis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →